Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug Project

New England Journal of Medicine

Volumn 303, Issue 18, 1980, Pages 1038-1041

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CLOFIBRATE; CONJUGATED ESTROGEN; NICOTINIC ACID; PLACEBO; THYROXINE;

CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; HEART; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; THERAPY;

ADULT; CHOLESTEROL; CLINICAL TRIALS; CLOFIBRATE; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROGNOSIS; RANDOM ALLOCATION; RISK; TIME FACTORS;

EID: 0018962999     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198010303031804     Document Type: Article

References (11)

1. Armitage P., McPherson C.K., Rowe B.C. Repeated significance tests on accumulating data. J R Statist Soc [A]. 1969; 132:235-244.
2. Canner P.L. Monitoring treatment differences in long-term clinical trials. Biometrics. 1977; 33:603-615.
3. Lee K.L., McNeer J.F., Starmer C.F., Harris P.J., Rosati R.A. Clinical judgment and statistics: lessons from a simulated randomized trial in coronary artery disease. Circulation. 1980; 61:508-515.
4. Coronary Drug Project Research Group. The Coronary Drug Project: findings leading to further modifications of its protocol with respect to dextrothyroxine. JAMA. 1972; 220:996-1008.
5. Canner P.L. Monitoring clinical trial data for evidence of adverse or beneficial treatment effects. In: Boissel JP. Klimt CR, eds. Essais controles multicentres: principes et problemes (Multi-center controlled trials: principles and problems). Paris: INSERM, 1979: 131-49.
6. Sackett D.L., Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med. 1979; 301:1410-1412.
7. Coronary Drug Project Research Group. The Coronary Drug Project: design, methods, and baseline results. Circulation. 1973; 47 & 48: Suppl 1:I-1-179.
8. Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA. 1975; 231:360-381.
9. Coronary Drug Project Research Group. Factors influencing long-term prognosis after recovery from myocardial infarction - three-year findings of the Coronary Drug Project. J Chronic Dis. 1974; 27:267-285.
10. Brownlee K.A. Statistical theory and methodology in science and engineering. 2nd ed. New York: John Wiley, 1965.
11. Feinstein A.R. Clinical biostatistics. XLI. Hard science, soft data, and the challenges of choosing clinical variables in research. Clin Pharmocol Ther. 1977; 22:485-498.